Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3740580012 | Heparinoid and salicylic acid only product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3740581011 | Product containing only heparinoid and salicylic acid in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5564881000241113 | produit contenant seulement de l'héparinoïde et de l'acide salicylique sous forme transdermique | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Heparinoid and salicylic acid only product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
Heparinoid and salicylic acid only product in transdermal dose form | Is a | Heparinoid- and salicylic acid-containing product in transdermal dose form | true | Inferred relationship | Some | ||
Heparinoid and salicylic acid only product in transdermal dose form | Has active ingredient | Heparinoid (substance) | true | Inferred relationship | Some | 1 | |
Heparinoid and salicylic acid only product in transdermal dose form | Has active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
Heparinoid and salicylic acid only product in transdermal dose form | Is a | Heparinoid and salicylic acid only product | true | Inferred relationship | Some | ||
Heparinoid and salicylic acid only product in transdermal dose form | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
Heparinoid and salicylic acid only product in transdermal dose form | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | True | Heparinoid and salicylic acid only product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets